Quick Answer
Anixa Biosciences Inc reported Total Revenue of $210.0 thousand for fiscal year 2023.
Anixa Biosciences Inc Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2023 | $210.0K | -59.0% |
| 2021 | $512.0K | +104.8% |
| 2019 | $250.0K | -77.5% |
| 2018 | $1.11M | +206.9% |
| 2017 | $362.5K | +20.8% |
| 2016 | $300.0K | -96.8% |
| 2015 | $9.26M | +152.4% |
| 2014 | $3.67M | +843.1% |
| 2013 | $388.9K | -58.9% |
| 2012 | $947.1K | -5.6% |
| 2011 | $1.00M | +37.3% |
| 2010 | $730.7K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| April 30, 2023 | $210.0K | — | -59.1% |
| January 31, 2021 | $513.0K | — | +105.2% |
| April 30, 2019 | $250.0K | -66.7% | -31.0% |
| July 31, 2018 | $362.5K | +0.0% | -51.7% |
| April 30, 2018 | $750.0K | — | +106.9% |
| July 31, 2017 | $362.5K | +262.5% | +262.5% |
| July 31, 2016 | $100.0K | +5.3% | +5.3% |
| July 31, 2015 | $95.0K | -92.0% | +280.0% |
- Anixa Biosciences Inc showed a decrease of -59.0% in Total Revenue compared to the prior fiscal year.
- Over the 2010–2023 period, Anixa Biosciences Inc’s total revenue has declined by 71.3% (from $730.7 thousand to $210.0 thousand).
- The most recent figure is from Anixa Biosciences Inc’s fiscal year 2024 report (Form 10-K), filed with the SEC on January 10, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: